Drugs / 23-valent pneumococcal conjugate vaccine (vaccine)
last change Jan 2006 re-read 2 minutes ago

23-valent pneumococcal conjugate vaccine (vaccine)

Investigated by
ANRS, Emerging Infectious Diseases · Wyeth is now a wholly owned subsidiary of Pfizer

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00148824 Feb 2003 → Jan 2006 HIV infectious disease ANRS, Emerging Infectious Diseases Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 23-valent pneumococcal conjugate vaccine (vaccine) ClinicalTrials.gov intervention name — accepted as the source's own label NCT00148824